1. Home
  2. RCEL vs NHS Comparison

RCEL vs NHS Comparison

Compare RCEL & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.33

Market Cap

171.5M

Sector

Health Care

ML Signal

HOLD

Logo Neuberger Berman High Yield Strategies Fund

NHS

Neuberger Berman High Yield Strategies Fund

HOLD

Current Price

$6.48

Market Cap

203.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCEL
NHS
Founded
N/A
2003
Country
United States
United States
Employees
226
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
171.5M
203.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RCEL
NHS
Price
$4.33
$6.48
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$7.88
N/A
AVG Volume (30 Days)
192.3K
184.6K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
13.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.17
N/A
Revenue Next Year
$49.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.22
$6.27
52 Week High
$7.12
$7.75

Technical Indicators

Market Signals
Indicator
RCEL
NHS
Relative Strength Index (RSI) 47.66 42.94
Support Level $4.02 $6.45
Resistance Level $4.57 $6.65
Average True Range (ATR) 0.28 0.05
MACD -0.02 0.02
Stochastic Oscillator 42.75 57.89

Price Performance

Historical Comparison
RCEL
NHS

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Share on Social Networks: